These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27045237)

  • 1. [Association of neuroendocrine differentiation with progression and prognosis of gastric adenocarcinoma].
    Xu F; Liu Q; Han F; Xu E; Lai M; Zhao Z
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 45(1):24-30. PubMed ID: 27045237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is neuroendocrine differentiation a prognostic factor in poorly differentiated colorectal cancer?
    Chen Y; Liu F; Meng Q; Ma S
    World J Surg Oncol; 2017 Mar; 15(1):71. PubMed ID: 28351413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopathologic features and prognostic analysis of 104 patients with gastric neuroendocrine neoplasms].
    Liang W; Gao Y; Li J; Cui J; Xi H; Cai A; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Apr; 19(4):427-31. PubMed ID: 27112478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine differentiation is a relevant prognostic factor in stage III-IV colorectal cancer.
    Grabowski P; Schindler I; Anagnostopoulos I; Foss HD; Riecken EO; Mansmann U; Stein H; Berger G; Buhr HJ; Scherübl H
    Eur J Gastroenterol Hepatol; 2001 Apr; 13(4):405-11. PubMed ID: 11338071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors of lymph node-negative metastasis gastric cancer].
    Sun D; Xu H; Huang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathological features of the primary gastric neuroendocrine neoplasms].
    Liang J; Liu S
    Zhonghua Zhong Liu Za Zhi; 2014 Jul; 36(7):522-8. PubMed ID: 25327658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma].
    Li B; Sun L; Wang X; Deng J; Ding X; Wang X; Ke B; Zhang L; Zhang R; Liang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):207-212. PubMed ID: 28226357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine tissue-specific transcription factor, BETA2/NeuroD, in gastric carcinomas: a comparison with chromogranin A and synaptophysin expressions.
    Fujii A; Kamiakito T; Takayashiki N; Fujii T; Tanaka A
    Pathol Res Pract; 2003; 199(8):513-9. PubMed ID: 14533935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine differentiation in gastric adenocarcinomas; correlation with tumor stage and expression of VEGF and p53.
    Eren F; Celikel C; Güllüoğlu B
    Pathol Oncol Res; 2004; 10(1):47-51. PubMed ID: 15029262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological features of primary gastric neuroendocrine neoplasms: A single-center analysis.
    Xu TM; Wang CS; Jia CW; Qian JM; Li JN
    J Dig Dis; 2016 Mar; 17(3):162-8. PubMed ID: 26860897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretagogin, a novel neuroendocrine marker, has a distinct expression pattern from chromogranin A.
    Lai M; Lü B; Xing X; Xu E; Ren G; Huang Q
    Virchows Arch; 2006 Oct; 449(4):402-9. PubMed ID: 16955307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
    Guo J; Zu G; Zhou T; Xing J; Wang Z
    Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beclin 1 expression is an independent prognostic factor for gastric carcinomas.
    Yu M; Gou WF; Zhao S; Xiao LJ; Mao XY; Xing YN; Takahashi H; Takano Y; Zheng HC
    Tumour Biol; 2013 Apr; 34(2):1071-83. PubMed ID: 23334926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance of neuroendocrine markers and somatostatin receptor 2 in hepatocellular carcinoma.
    Murakami K; Kumata H; Miyagi S; Kamei T; Sasano H
    Pathol Int; 2021 Oct; 71(10):682-691. PubMed ID: 34320691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of secretagogin as a marker for the diagnosis of lung neuroendocrine carcinoma.
    Baykara Y; Xiao Y; Yang D; Yakirevich E; Maleki S; Garcia-Moliner M; Wang LJ; Huang CK; Lu S
    Virchows Arch; 2022 Jul; 481(1):31-39. PubMed ID: 35357570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine features in poorly differentiated endometrioid adenocarcinomas of the endometrium.
    Tamura T; Jobo T; Watanabe J; Kanai T; Kuramoto H
    Int J Gynecol Cancer; 2006; 16(2):821-6. PubMed ID: 16681768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer.
    Zhang Q; Ye Z; Yang Q; He X; Wang H; Zhao Z
    World J Surg Oncol; 2012 Jun; 10():103. PubMed ID: 22681645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of clinicopathological characteristics, therapeutic strategy and prognosis of 501 patients with gastric neuroendocrine neoplasms attending a single center].
    Zhang BL; Lu YX; Liang WQ; Gao YH; Xi HQ; Wang XX; Zhang KC; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):459-466. PubMed ID: 37217354
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression and clinical significance of a new neuroendocrine marker secretagogin in cervical neuroendocrine carcinoma.
    Yu L; Suye S; Huang R; Liang Q; Fu C
    J Clin Pathol; 2021 Dec; 74(12):787-795. PubMed ID: 33060116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear overexpression of the overexpressed in lung cancer 1 predicts worse prognosis in gastric adenocarcinoma.
    Wang J; Shen H; Fu G; Zhao D; Wang W
    Oncotarget; 2017 Feb; 8(6):9442-9450. PubMed ID: 28038462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.